These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation. Frick M, Darpö B, Ostergren J, Rosenqvist M. Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301 [Abstract] [Full Text] [Related]
3. Hemodynamic performances in patients treated with sotalol after electrical cardioversion of atrial fibrillation. Dan GA, Gonţa A. Rom J Intern Med; 1997 Jul; 35(1-4):19-27. PubMed ID: 9562649 [Abstract] [Full Text] [Related]
4. [The influence of electrical cardioversion on left ventricular systolic function, left atrial size, ANP levels and enzymatic activity of CPK and CD-MB in serum of patients with paroxysmal atrial fibrillation]. Spring A, Kosmala W, Mysiak A. Przegl Lek; 1997 Jul; 54(9):585-90. PubMed ID: 9501676 [Abstract] [Full Text] [Related]
5. Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol. Plewan A, Lehmann G, Ndrepepa G, Schreieck J, Alt EU, Schömig A, Schmitt C. Eur Heart J; 2001 Aug; 22(16):1504-10. PubMed ID: 11482924 [Abstract] [Full Text] [Related]
6. Atrial fibrillation: rate control often better than rhythm control. Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984 [Abstract] [Full Text] [Related]
19. The predictive value of transthoracic echocardiographic variables for sinus rhythm maintenance after electrical cardioversion of atrial fibrillation. Results from the CAPRAF study, a prospective, randomized, placebo-controlled study. Grundvold I, Tveit A, Smith P, Seljeflot I, Abdelnoor M, Arnesen H. Cardiology; 2008 May; 111(1):30-5. PubMed ID: 18239389 [Abstract] [Full Text] [Related]